FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (kwalificatiewaarde)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    12718871000146116 1 (kwalificatiewaarde) nl Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
    12718881000146119 één nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
    13856651000146112 1 nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 (kwalificatiewaarde) Is a General adjectival modifier false Inferred relationship Some
    1 (kwalificatiewaarde) Is a Number false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Levothyroxine sodium anhydrous 150 microgram oral capsule Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Levothyroxine sodium anhydrous 150 microgram oral capsule Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely lapatinib (as lapatinib ditosylate) 250 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely lapatinib (as lapatinib ditosylate) 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Darunavir (as darunavir ethanolate) 600 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Darunavir (as darunavir ethanolate) 600 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Levothyroxine sodium anhydrous 50 microgram oral capsule Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Levothyroxine sodium anhydrous 50 microgram oral capsule Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing only tagraxofusp in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Fenoprofen (as fenoprofen calcium) 300 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Fenoprofen (as fenoprofen calcium) 300 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Levothyroxine sodium anhydrous 50 microgram oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Levothyroxine sodium anhydrous 50 microgram oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Flucloxacillin (as flucloxacillin sodium) 250 mg oral capsule Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Flucloxacillin (as flucloxacillin sodium) 250 mg oral capsule Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Imatinib (as imatinib mesilate) 400 mg oral capsule Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Imatinib (as imatinib mesilate) 400 mg oral capsule Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 15 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Levothyroxine sodium anhydrous 100 microgram oral capsule Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Levothyroxine sodium anhydrous 100 microgram oral capsule Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing only andexanet alfa (medicinal product) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only calaspargase pegol in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Rifamycin only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Calaspargase pegol only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only rifamycin in oral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only andexanet alfa in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only barium sulfate (medicinal product) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Cyanocobalamin (57-Co) only product in oral dose form Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Iodohippurate (123-I) sodium only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only norcholestenol iodomethyl (131-I) (medicinal product) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Chromic phosphate (32-P) only product in parenteral dose form Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only sodium iodide (131-I) (medicinal product) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Norcholestenol iodomethyl (131-I) only product in parenteral dose form Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Sodium iodide (131-I) only product in parenteral dose form Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Iothalamic acid only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only iodohippurate (123-I) sodium in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Hydroxyapatite only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Iodinated (125-I) human serum albumin only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Sodium iodide (131-I) only product in oral dose form Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Hydroxyapatite only product in parenteral dose form Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only indigotindisulfonate sodium in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only iodinated (125-I) human serum albumin in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Mangafodipir only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only indigotindisulfonate sodium (medicinal product) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Cyanocobalamin (58-Co) only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only cyanocobalamin (57-Co) (medicinal product) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only mangafodipir in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only cyanocobalamin (58-Co) in oral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only chromic phosphate (32-P) (medicinal product) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely pemirolast potassium 1 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely pemirolast potassium 1 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely pemirolast potassium 1 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 3
    Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely tramadol hydrochloride 50 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely tramadol hydrochloride 50 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Aspirin 81 mg chewable tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Aspirin 81 mg chewable tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet Has presentation strength numerator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Ropinirole (as ropinirole hydrochloride) 8 mg prolonged-release oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Ropinirole (as ropinirole hydrochloride) 8 mg prolonged-release oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Paracetamol 80 mg chewable tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Paracetamol 80 mg chewable tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 3
    Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Prednisolone acetate 1.25 mg/mL eye suspension Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Prednisolone acetate 1.25 mg/mL eye suspension Has concentration strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely valproic acid 125 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely valproic acid 125 milligram/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Zolmitriptan 5 mg orodispersible tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Zolmitriptan 5 mg orodispersible tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some

    Start Previous Page 169 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start